|
CO-ADMINISTRATION WITH ANTIPLATELET AGENTS MAY BE ASSOCIATED WITH AN INCREASE IN BLEEDING.
|
CO-ADMINISTRATION WITH ANTIPLATELET AGENTS MAY BE ASSOCIATED WITH AN INCREASE IN BLEEDING.
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
POTENTIAL FOR INCREASED MYELOTOXICITY AND NEPHROTOXICITY
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED PROTHROMBIN TIME, WITH OR WITHOUT CLINICAL BLEEDING
|
BARBITURATES INCREASE ITS METABOLISM LEADING TO REDUCED EFFICACY
|
CO-ADMINISTRATION WITH TETRACYCLINES MAY INCREASE DIGOXIN ABSORPTION IN PATIENTS WITH INACTIVATE DIGOXIN BY BACTERIAL METABOLISM IN THE LOWER INTESTINE, SO THAT DIGITALIS INTOXICATION MAY RESULT
|
CO-ADMINISTRATION WITH TETRACYCLINES MAY INCREASE DIGOXIN ABSORPTION IN PATIENTS WITH INACTIVATE DIGOXIN BY BACTERIAL METABOLISM IN THE LOWER INTESTINE, SO THAT DIGITALIS INTOXICATION MAY RESULT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
MOLYBDENUM IMPAIRES THE ABSORPTION OF THE DRUG
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
CO-ADMINISTRATION WITH ANTACIDS CONTAINING ALUMINUM, MAGNESIUM, AND CALCIUM MAY IMPAIR ORAL ABSORPTION OF TETRACYCLINES
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
DECREASES THE HALF-LIFE OF DOXYCYCLINE
|
DECREASES THE HALF-LIFE OF DOXYCYCLINE
|
DECREASES THE HALF-LIFE OF DOXYCYCLINE
|
DECREASES THE HALF-LIFE OF DOXYCYCLINE
|
DECREASES THE HALF-LIFE OF DOXYCYCLINE
|
DECREASES THE HALF-LIFE OF DOXYCYCLINE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|
CONCURRENT USE MAY RENDER ORAL CONTRACEPTIVE LESS EFFECTIVE
|